Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

The therapeutic efficacy of the immunoglobulin G1 (IgG1) monoclonal antibody (MAb) 2H1 to the Cryptococcus neoformans capsular polysaccharide was studied with and without amphotericin B (AmB) in a murine model of intravenous (i.v.) infection. MAb and AmB were administered by intraperitoneal (i.p.) i...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Mukherjee, J, Zuckier, L S, Scharff, M D, Casadevall, A
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1994
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284501/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203858/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.580
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!